Benzinga | Nov 9, 2020 09:20AM EST

Capricor Therapeutics Q3 EPS $(0.20) Up From $(0.43) YoY

Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.20) per share. This is a 53.49 percent increase over losses of $(0.43) per share from the same period last year.